The following trials provide information to treat various types of cardiovascular diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse A PK study of NXY-059 in renal impaired subjects
- collapse Safety and tolerability in patients with stroke
- collapse Evaluation of Target Organs Damage in Hypertensive Patients With no Known Cardiovascular (CV) or Renal Disease, Stratified According to Level of Blood Pressure Control
- collapse A Phase I, Single Centre, Open Study to Assess the Pharmacokinetics of oral AZD6140 after Single Dose in Healthy Japanese Male Volunteers
- collapse A Single-Center,Open-Label,Randomized,3-Treatment,3-Period Cross-Over Study to Investigate the Potential Effect of Cyclosporine on the Pharmacokinetics, Safety, and Tolerability of Ticagrelor and the Effect of Ticagrelor on the Pharmacokinetics, Safety, and Tolerability of Cyclosporine
- collapse A 4-month treatment, Randomized, Double-blind, Placebo-Controlled, Multi-centre, Parallel-Group Phase 2 study to Evaluate Efficacy, Safety and Tolerability of Different Dosing Regimens of AZD1656 as Monotherapy in Japanese Type 2 Diabetes Mellitus Patients
- collapse A 4-month, Randomized, Double-blind, Placebo- and Active-Controlled, Multi-centre, Parallel-Group study, with an optional 2-month extension, to Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus Patients
- collapse A double blind, double dummy, phase IV, randomized, multicenter, parallel group, placebo control trial to evaluate the effect of rosuvastatin on triglycerides levels in Mexican hypertriglyceridemic patients.
- collapse A non interventional, cross sectional, retrospective, epidemiological study on the management of dyslipidemia in Type 2 DM adult patients in India
- collapse A Non Interventional, Cross Sectional, Study on the Prevalence of Sympathetic Overactivity in Hypertensive Patients.
